News Briefing channel feed

Broad In­sti­tute's Er­ic Lan­der con­firmed to Biden cab­i­net; Leg­end re­veals the BC­MA CAR-T da­ta pack­age be­hind pri­or­i­ty re­view

4 years ago

Chi­na's patent law re­vi­sions set to take ef­fect June 1; Ver­ri­ca's sec­ond trip to the FDA is de­layed

4 years ago

Astel­las out­lines an­oth­er five-year plan; Bay­er's VC arm leaps in­to dig­i­tal health

4 years ago

PureTech's video game for AD­HD gets big Se­ries D fi­nanc­ing; Day One in­creas­es term sheet ahead of ex­pect­ed IPO

4 years ago

New da­ta point to how Keytru­da changed lung can­cer treat­ment; A Hous­ton biotech earns ear­ly back­ers in quest to turn 'cold' tu­mors 'hot'

4 years ago

Ve­rastem wins break­through nod for com­bo ther­a­py in ovar­i­an can­cer; EMA picks up speedy re­view of Bio­Mar­in's gene ther­a­py

5 years ago

An­no­vis Bio claims wins in Alzheimer's and Parkin­son's, shares sky­rock­et; FDA de­lays de­ci­sion for Omeros' nar­so­plimab

5 years ago

Bio­Th­eryX col­lects $92M in Se­ries E round; WuXi Bi­o­log­ics ups its stake in an emerg­ing ADC play­er

5 years ago

Idera of­fi­cial­ly puts to rest its Phase III tri­al in ad­vanced melanoma; BeiGene nabs pri­or­i­ty re­view for sN­DA

5 years ago

Lil­ly and In­novent look to bring their an­ti-PD-1 from Chi­na to the US; Mer­ck KGaA names new EMD Serono pres­i­dent

5 years ago

John­son & John­son do­nates Ebo­la vac­cine amid new out­break; Ji Xing promis­es more than $127M for Mile­stone's nasal spray for rapid heart rate

5 years ago

Scynex­is takes out $60M loan ahead of ex­pect­ed ap­proval; Com­pass Ther­a­peu­tics ac­quires new bis­pe­cif­ic an­ti­body in buy­out

5 years ago

AI life sci­ences uni­corn rais­es $150M for plat­form ops; 10 rare dis­ease com­pa­nies form new lob­by­ing group

5 years ago

Sanofi, Cel­lec­tis team up to pair Lem­tra­da with al­lo­gene­ic CAR-Ts; Bris­tol My­ers joins Evotec's dri­ve to ad­vance UK sci­ence

5 years ago

Prothena col­lects $60M Parkin­son's mile­stone from Roche; As­traZeneca's Pas­cal So­ri­ot faces proxy push­back on pay pack­age

5 years ago

British CRO wins con­tract for Covid-19 chal­lenge virus; Dutch agency aims to slash Zol­gens­ma prices in half

5 years ago

In­cyte ponies up $12M to set­tle char­i­ty foun­da­tion kick­back claims; US ex­er­cis­es op­tion for more dos­es of mon­key­pox vac­cine

5 years ago

Keytru­da gets ac­cel­er­at­ed OK in HER2-pos­i­tive gas­tric can­cer; Twin­Strand gets $50M to hunt for 'nee­dles in a haystack'

5 years ago

Clo­vis spikes ovar­i­an can­cer com­bo af­ter 'un­der­whelm­ing' ef­fi­ca­cy; Servi­er wins pri­or­i­ty re­view for Tib­so­vo ex­pan­sion

5 years ago

Se­quenc­ing up­start rais­es $273M ahead of IPO; Ac­er­a­gen ac­quires high­ly-an­tic­i­pat­ed Far­ber dis­ease treat­ment

5 years ago

News brief­ing: Gy­ro­scope and Ta­laris set IPO terms; FDA grants ex­pand­ed nod to Chiesi's sick­le cell drug

5 years ago

J&J bids for EU OK on Leg­end CAR-T; FDA ex­tends re­view pe­ri­od for Arde­lyx's phos­pho­rus con­trol drug

5 years ago

Galera claims pos­i­tive up­date in pan­cre­at­ic can­cer but does­n't re­port p-val­ues; Am­gen launch­es Cana­di­an fund in tan­dem with CCRM

5 years ago

BeiGene's late stage tri­al shows promis­ing num­bers; Am­gen to study so­tora­sib dosage af­ter FDA rec­om­men­da­tion

5 years ago
First page Previous page 30313233343536 Next page Last page
A service from the Financial Times